Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/1997
03/27/1997WO1997011188A1 Plants which synthesise a modified starch, process for the production thereof and modified starch
03/27/1997WO1997011182A1 New adhesin from helicobacter pylori
03/27/1997WO1997011178A1 Human growth hormone variants
03/27/1997WO1997011163A1 Pskh-1 ribozymes and uses in disease treatment
03/27/1997WO1997011162A1 Production and use of type 5 17beta-hydroxysteroid dehydrogenase
03/27/1997WO1997011156A2 Laser cell purification system
03/27/1997WO1997011094A1 Novel variants of green fluorescent protein, gfp
03/27/1997WO1997010851A2 Nucleic acid delivery vehicle
03/27/1997WO1997010850A1 Transcytosis vehicles and enhancers for drug delivery
03/27/1997WO1997010837A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
03/27/1997WO1997010796A2 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2Cα - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION
03/27/1997WO1996040082A3 Apparatus and method for delivering a biologically active compound into a biological environment
03/27/1997DE19547272C1 Expression system for anaerobic gene expression in plants
03/27/1997DE19535321A1 Neues Adhäsin aus Helicobacter pylori Create an adhesin of Helicobacter pylori
03/27/1997CA2658039A1 Human growth hormone variants
03/27/1997CA2232730A1 New adhesin from helicobacter pylori
03/27/1997CA2232500A1 Production and use of type 5 17beta-hydroxysteroid dehydrogenase
03/27/1997CA2232301A1 Pskh-1 ribozymes and uses in disease treatment
03/27/1997CA2231172A1 Nucleic acid delivery vehicle
03/27/1997CA2230479A1 Transcytosis vehicles and enhancers for drug delivery
03/26/1997EP0764721A1 ATP-sensitive potassium-channel proteins and genes for the same
03/26/1997EP0764719A2 Methods for animal cell culture
03/26/1997EP0764213A1 Recombinant aav genome encoding immunodeficiency virus protein
03/26/1997EP0764212A1 Use of anthocyanin genes to maintain male sterile plants
03/26/1997EP0764210A1 Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
03/26/1997EP0764203A1 Methods for selectively stimulating proliferation of t cells
03/26/1997EP0764171A1 Ligands for induction of antigen specific apoptosis in t cells
03/26/1997EP0764047A1 Polymeric microbeads and method of preparation
03/26/1997EP0764030A1 Use of autoantibodies for tumor therapy and prophylaxis
03/26/1997EP0698096B1 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds
03/26/1997EP0436007B1 Process for the site-directed integration of dna into the genome of plants
03/26/1997CN1146207A Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
03/26/1997CN1146156A Means for treating auto-immune diseases and method of treatment
03/26/1997CN1146155A Method for implanting encapsulated cells in a host
03/26/1997CN1146136A Targeted cytolysis of HIV-infected cells by Chimeric CD4 receptor bearing cells
03/25/1997US5614611 Humanized monoclonal antibodies binding to IgE-bearing B cells but not basophils
03/25/1997US5614609 Serine threonine kinase receptor
03/25/1997US5614407 Administering 6-(substituted amino)purine cytokinins
03/25/1997US5614406 Kainate-binding human CNS receptors of the EAA2 family
03/25/1997US5614394 Immunizing mice, fusion of lymphocytes and myeloma cells
03/25/1997US5614393 Production of γ-linolenic acid by a Δ6-desaturase
03/25/1997US5614385 Morphogens
03/25/1997US5614381 Method for the inducible production of proteins in genetically modified eukaryotic host-cells multiplied in vivo
03/25/1997US5614195 Coccidiosis poultry vaccine
03/25/1997US5614191 Antitumor
03/25/1997US5614190 Tissue plasminogen activator having zymogenic or fibrin specific properties
03/25/1997US5614187 Conferring tolerance to foreign tissue in recipient mammal
03/25/1997US5613982 Method of preparing transplant tissue to reduce immunogenicity upon implantation
03/25/1997CA2050479C Cd3 specific recombinant antibody
03/25/1997CA1339014C Antibodies to a4 amyloid peptide
03/25/1997CA1339013C Cross-protective human monoclonal antibody compositions
03/20/1997WO1997010505A1 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc¿
03/20/1997WO1997010354A1 ANTIBODY AGAINTS α-CHAIN OF HUMAN INTERLEUKIN 5 RECEPTOR
03/20/1997WO1997010348A1 Methods for inducing selected cell types
03/20/1997WO1997010339A1 Flowering genes
03/20/1997WO1997010336A1 A kinase anchoring protein and uses thereof
03/20/1997WO1997010334A2 Ribozyme therapy for the treatment and/or prevention of restenosis
03/20/1997WO1997010329A1 Neural transplantation using pluripotent neuroepithelial cells
03/20/1997WO1997010328A2 Compositions and method for modulation of gene expression in plants
03/20/1997WO1997010269A1 Immunotherapeutic methods using tumor antigenic peptides coated on cells and vaccines made thereof
03/20/1997WO1997010265A1 Nitrosated hemoglobins and therapeutic uses therefor
03/20/1997WO1997010249A1 Toxoplasma gondii glycoconjugates
03/20/1997WO1997010006A1 Method for inhibiting cell-mediated killing of target cells
03/20/1997WO1997009972A1 Erythrocytes loaded with s-nitrosothiol and uses therefor
03/20/1997WO1997009885A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration
03/20/1997WO1997004114A3 Isolated dna sequence for use as a regulator region in a chimeric gene useful for transforming plants
03/20/1997WO1997004103A3 Mutated 5-enol pyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene
03/20/1997WO1997000952A3 A human edg-2 receptor homolog
03/20/1997WO1996025498A3 Mpl ligand analogs
03/20/1997CA2232262A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration
03/20/1997CA2232043A1 Nitrosated hemoglobins and therapeutic uses therefor
03/20/1997CA2232012A1 Toxoplasma gondii glycoconjugates
03/20/1997CA2231804A1 Method for inhibiting cell-mediated killing of target cells
03/20/1997CA2231685A1 Ribozyme therapy for the treatment and/or prevention of restenosis
03/20/1997CA2226728A1 Compositions and method for modulation of gene expression in plants
03/19/1997EP0763543A2 A method for preparing an inflammatory cytokine (MIP-2) and diagnostic and therapeutic applications for the cytokine or its antibody
03/19/1997EP0763124A1 Method for introducing nucleic acid in higher eukaryotic cells
03/19/1997EP0763122A1 Retroviral gene therapy vectors and therapeutic methods based thereon
03/19/1997EP0763120A1 Safe vectors for gene therapy
03/19/1997EP0763118A1 Transgenic plants producing trehalose
03/19/1997EP0763116A1 Recombinant viruses, preparation and use thereof in gene therapy
03/19/1997EP0763109A1 Factor interacting with nuclear proteins
03/19/1997EP0763108A1 Dna sequences
03/19/1997EP0763107A1 Pantropic neurotrophic factors
03/19/1997EP0763106A1 Methods and compositions for treatment of restenosis and cancer using ribozymes
03/19/1997EP0763105A1 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof
03/19/1997EP0763104A1 Human dna topoisomerase i-alpha
03/19/1997EP0763103A1 Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line
03/19/1997EP0763102A1 Serum-free medium supplement
03/19/1997EP0763059A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments
03/19/1997EP0763058A1 $i(RPS) GENE FAMILY, PRIMERS, PROBES, AND DETECTION METHODS
03/19/1997EP0763057A1 Method for proliferating and differentiating b cells, and uses thereof
03/19/1997EP0763045A1 Haemopoietic maturation factor
03/19/1997EP0762891A1 Immunogenic pharmaceuticals
03/19/1997EP0762889A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
03/19/1997EP0762885A1 Glial mitogenic factors, their preparation and use
03/19/1997EP0596881B1 Expression in non-tumoral human lymphoblastoid lines with an integrative vector
03/19/1997EP0561965A4 Enhancement of musculature in animals
03/19/1997CN1145640A Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells
03/19/1997CN1145638A Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs